Pharma & Biotech

Pharma & Biotech

As the pace of innovation in precision therapies accelerates, so do the challenges in bringing these transformative therapies to patients. Navigating evolving clinical trial, regulatory, manufacturing, and market access landscapes requires precise market insights and novel strategies.

Client Results

Our Impact

See how we’ve helped ambitious clients achieve extraordinary outcomes.

See ALL Client Results

Biomarker and Diagnostic Strategy

Due Diligence

KOL Identification

Revenue Projection

Go-to-Market Strategy

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

Voice-Of-Customer Research

Biomarker and Diagnostic Strategy

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

Voice-Of-Customer Research

Pricing Strategy

Pharma & Biotech

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

Voice-Of-Customer Research

Due Diligence

Pharma & Biotech

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

Voice-Of-Customer Research

Competitive Analysis

Featured Team

Andrew Aijian

David Cavanaugh

Founding Partner

Carl Schoellhammer

Colin Enderlein

Data & Platforms

Platform

BioTrack

BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.

Platform

BioTrack

BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.

Platform

BioTrack

BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.

Platform

Dexter Expert Network

Browse our network of life sciences advisors and schedule 1:1s or pulse surveys to gain the targeted insights you need to test the market, launch a product, or discover a new opportunity.

Platform

Dexter Expert Network

Browse our network of life sciences advisors and schedule 1:1s or pulse surveys to gain the targeted insights you need to test the market, launch a product, or discover a new opportunity.

Platform

Dexter Expert Network

Browse our network of life sciences advisors and schedule 1:1s or pulse surveys to gain the targeted insights you need to test the market, launch a product, or discover a new opportunity.

Market Report

Global Oncology Liquid Biopsy Market

Liquid biopsies (LBx), which, to-date, have been used largely for genomic profiling and therapy selection, are finding new applications throughout the patient journey and within pharma research. To help predict the future state of the market, we have developed an evaluation framework to identify and assess areas of growth within the liquid biopsy market.

Market Report

Global Oncology Liquid Biopsy Market

Liquid biopsies (LBx), which, to-date, have been used largely for genomic profiling and therapy selection, are finding new applications throughout the patient journey and within pharma research. To help predict the future state of the market, we have developed an evaluation framework to identify and assess areas of growth within the liquid biopsy market.

Market Report

Global Oncology Liquid Biopsy Market

Liquid biopsies (LBx), which, to-date, have been used largely for genomic profiling and therapy selection, are finding new applications throughout the patient journey and within pharma research. To help predict the future state of the market, we have developed an evaluation framework to identify and assess areas of growth within the liquid biopsy market.

Market Report

Oncology Biomarker Market Assessment

Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.

Market Report

Oncology Biomarker Market Assessment

Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.

Market Report

Oncology Biomarker Market Assessment

Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.

Proprietary Database

TheraTrack

Next generation therapy trackers (TheraTrack) platform includes dynamic, up-to-date trackers of assets in development across cell therapies, viral gene therapies, nucleic acid based therapies, and antibody-drug conjugates.

Proprietary Database

TheraTrack

Next generation therapy trackers (TheraTrack) platform includes dynamic, up-to-date trackers of assets in development across cell therapies, viral gene therapies, nucleic acid based therapies, and antibody-drug conjugates.

Proprietary Database

TheraTrack

Next generation therapy trackers (TheraTrack) platform includes dynamic, up-to-date trackers of assets in development across cell therapies, viral gene therapies, nucleic acid based therapies, and antibody-drug conjugates.

Latest Insights

Pharma & Biotech

Next-Generation Therapeutics Newsletter | January

Read our latest newsletter, recapping major developments in the Next-Generation Therapeutics space.

January 31, 2023

Pharma & Biotech

Digital Health | Q4 2022 Update

The final quarter of 2022 had exciting developments, from new releases from the FDA and Federal Trade Commission to big partnerships from Mayo Clinic and Google Cloud. Read about it in our latest newsletter.

January 19, 2023

Pharma & Biotech

Methylation Analysis 2022 Year-In-Review

Explore the key developments in the methylation analysis market from leading companies over the course of 2022.

January 11, 2023

Pharma & Biotech

Women’s Health Today and Tomorrow: DeciBio's Q&A with Fanny Anderson, Global Market Development Manager at Illumina

Read our latest Q&A with Fanny Anderson, Senior Global Market Development Manager at Illumina.

January 10, 2023

View All Insights

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.